Skip to content

CDR

Avella to improve access to Naloxone

Avella to improve access to Naloxone

Avella has announced it will distribute naloxone, a powerful therapy used to treat opioid overdoses, as part of an innovative new program designed to improve access to the drug.

NACDS Foundation announces scholarships, grants

NACDS Foundation announces scholarships, grants

PALM BEACH, Fla. –The NACDS Foundation has distributed $220,000 in scholarships and grants as part of an ongoing commitment to advancing patient care through pharmacy education as part of the 23rd Annual NACDS Foundation Scholarship Program.

Lupin gets FDA approval for generic Xenazine tablets

Lupin gets FDA approval for generic Xenazine tablets

Lupin announced today that it has received final approval for its Tetrabenazine tablets, 12.5 mg and 25 mg from the United States Food and Drug Administration (FDA) to market a generic version of Valeant Pharmaceuticals North America’s  Xenazine tablets, 12.5 mg and 25 mg.

NACDS names new officers, board members

NACDS names new officers, board members

PALM BEACH, Fla. –  The National Association of Chain Drug Stores has elected new officers, and executive committee and board  members for the coming year. The appointments were announced at the NACDS Annual Meeting.

Coty unveils makeup try-on experience with AR

Coty unveils makeup try-on experience with AR

Coty has unveiled a a first-of-a-kind augmented reality (AR) makeup try-on experience. The company debuted the blended reality Magic Mirror — which  integrates physical products with digital content — at its newly relaunched Bourjois boutique in Paris.

IPO plan pulled by Albertsons

Albertsons Cos. has withdrawn its plan for an initial public offering. In its filing with the Securities and Exchange Commission, Albertsons noted that the registration statement for the offering was originally filed by the company on July 8, 2015, and was most recently amended on November 8, 2017.